The pharmaceutical industry is increasingly leveraging advanced AI technologies to address its most pressing challenges. Artificial intelligence (AI) is used to automate tasks traditionally reliant on human intelligence, such as optimizing process design and control, smart monitoring and maintenance, and trend monitoring. AI can also predict pharmacokinetics, enhancing the effectiveness and affordability of drug research through computer modeling. AI technology development can be divided into two main categories: traditional computational methods and systems that utilize artificial neural networks (ANNs) to simulate brain functions. Machine learning algorithms have been employed by Novartis to anticipate themes that are not previously identified but could be worthy of further study, speding up the screening process. Leading biopharmaceutical businesses are using AI to improve patient outcomes through mobile platforms and drug discovery.The evolving pharmaceutical field has always focused on small-molecule pharmaceuticals with three intrinsic qualities: stability, adequate potency for therapeutic applications, and acceptable toxicity for the majority of users. Artificial intelligence applications in medication delivery and nanotechnology have been driving forces behind the biotech and pharmaceutical industries. Quality-by-design R&D has been crucial to the modern pharmaceutical evolution toward better drug delivery.AI can enhance nanosystem design by facilitating a better understanding of the biological environment, allowing pharmaceutical items to be nanoengineered. In formulation, neural networks with a hidden layer were found to be effective in predicting drug release. In product development, the expandability of neural networks makes them suitable for resolving issues with establishing quality in the manufacturing of consumer goods.